Apo-Perindopril Arginine 2.5 mg, 5 mg and 10 mg tablets (bottle) - extended recall (new batches)
Published 12 November 2017
Product
Apo-Perindopril Arginine is a medicine used to treat high blood pressure, heart failure or coronary artery disease. 15 batches of APO-Perindopril Arginine are affected: APO-Perindopril Arginine 2.5mg Batch/Lot Number: (L)NC6619 Expiry: 02/2020 Batch/Lot Number: (L)NC6620 Expiry: 02/2020 Batch/Lot Number: (L)MX1699 Expiry: 05/2019 Batch/Lot Number: (L)MX1697 Expiry: 05/2019 Batch/Lot Number: (L)MX1698 Expiry: 05/2019 AUST R: 184808 APO-Perindopril Arginine 5mg Batch/Lot Number: (L)NC6671 Expiry: 03/2020 Batch/Lot Number: (L)NC6670 Expiry: 03/2020 Batch/Lot Number: (L)MX1702 Expiry: 05/2019 Batch/Lot Number: (L)NC6672 Expiry: 03/2020 Batch/Lot Number: (L)MX1700 Expiry: 05/2019 Batch/Lot Number: (L)MX1701 Expiry: 05/2019 AUST R: 184806 APO-Perindopril Arginine 10mg Batch/Lot Number: (L)MX1705 Expiry: 05/2019 Batch/Lot Number: (L)MX1703 Expiry: 05/2019 Batch/Lot Number: (L)MX1704 Expiry: 05/2019 Batch/Lot Number: (L)NC6729 Expiry: 03/2020 AUST R: 184812
Why it was recalled
It has been identified that some bottles from these batches may be contaminated with dark particles of silica, presumably released from the desiccant cylinder that is placed inside the bottle to keep the contents dry and protected from moisture. The particles may be large enough to see as specks or appear as a dust that discolours the tablets themselves and/or the inside of the bottle.
Hazard
This potential contamination is classified as a quality defect and is not considered to impact product safety or efficacy.
Source: Product Safety Australia. RecallMatch AU provides a screening summary and is independent of the ACCC.